A Phase 2, Randomized, Open-Label Study of the Safety, Antiviral Activity, and Pharmacokinetics..... Grant uri icon

date/time interval

  • November 20, 2006 - October 12, 2009

total award amount

  • 117198.00

direct costs

  • 93757.60

sponsor award ID

  • 3173A1-200-US

local award ID

  • 00062852